- Home
- STRO vs INTT Comparison
STRO vs INTT Comparison
Compare STRO & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- INTT
- Stock Information
- Founded
- STRO 2003
- INTT 1981
- Country
- STRO United States
- INTT United States
- Employees
- STRO N/A
- INTT N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- INTT Semiconductors
- Sector
- STRO Health Care
- INTT Technology
- Exchange
- STRO Nasdaq
- INTT Nasdaq
- Market Cap
- STRO 77.7M
- INTT 77.3M
- IPO Year
- STRO 2018
- INTT 1997
- Fundamental
- Price
- STRO $0.88
- INTT $7.39
- Analyst Decision
- STRO Hold
- INTT Strong Buy
- Analyst Count
- STRO 7
- INTT 2
- Target Price
- STRO $3.97
- INTT $12.00
- AVG Volume (30 Days)
- STRO 513.9K
- INTT 24.4K
- Earning Date
- STRO 08-12-2025
- INTT 08-06-2025
- Dividend Yield
- STRO N/A
- INTT N/A
- EPS Growth
- STRO N/A
- INTT N/A
- EPS
- STRO N/A
- INTT N/A
- Revenue
- STRO $66,434,000.00
- INTT $127,503,000.00
- Revenue This Year
- STRO N/A
- INTT N/A
- Revenue Next Year
- STRO N/A
- INTT $10.07
- P/E Ratio
- STRO N/A
- INTT N/A
- Revenue Growth
- STRO N/A
- INTT 5.19
- 52 Week Low
- STRO $0.52
- INTT $5.24
- 52 Week High
- STRO $5.17
- INTT $11.18
- Technical
- Relative Strength Index (RSI)
- STRO 57.66
- INTT 52.25
- Support Level
- STRO $0.83
- INTT $7.18
- Resistance Level
- STRO $1.01
- INTT $7.88
- Average True Range (ATR)
- STRO 0.07
- INTT 0.40
- MACD
- STRO 0.01
- INTT -0.04
- Stochastic Oscillator
- STRO 51.67
- INTT 45.56
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About INTT inTest Corporation
inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.